Caseware UK (AP4) 2024.0.164 2024.0.164 2025-08-312025-08-31falsetruetruetruetrue2024-09-01false22truefalse 09423979 2024-09-01 2025-08-31 09423979 2023-09-01 2024-08-31 09423979 2025-08-31 09423979 2024-08-31 09423979 1 2024-09-01 2025-08-31 09423979 d:Director1 2024-09-01 2025-08-31 09423979 d:Director2 2024-09-01 2025-08-31 09423979 d:RegisteredOffice 2024-09-01 2025-08-31 09423979 c:FurnitureFittings 2024-09-01 2025-08-31 09423979 c:FurnitureFittings 2025-08-31 09423979 c:FurnitureFittings 2024-08-31 09423979 c:CurrentFinancialInstruments 2025-08-31 09423979 c:CurrentFinancialInstruments 2024-08-31 09423979 c:CurrentFinancialInstruments c:WithinOneYear 2025-08-31 09423979 c:CurrentFinancialInstruments c:WithinOneYear 2024-08-31 09423979 c:ReportableOperatingSegment1 2024-09-01 2025-08-31 09423979 c:ReportableOperatingSegment1 2023-09-01 2024-08-31 09423979 e:UnitedKingdom 2024-09-01 2025-08-31 09423979 e:UnitedKingdom 2023-09-01 2024-08-31 09423979 e:RestEuropeOutsideUK 2024-09-01 2025-08-31 09423979 e:RestEuropeOutsideUK 2023-09-01 2024-08-31 09423979 e:RestWorldOutsideUK 2024-09-01 2025-08-31 09423979 e:RestWorldOutsideUK 2023-09-01 2024-08-31 09423979 c:UKTax 2024-09-01 2025-08-31 09423979 c:UKTax 2023-09-01 2024-08-31 09423979 c:ShareCapital 2025-08-31 09423979 c:ShareCapital 2024-08-31 09423979 c:RetainedEarningsAccumulatedLosses 2024-09-01 2025-08-31 09423979 c:RetainedEarningsAccumulatedLosses 2025-08-31 09423979 c:RetainedEarningsAccumulatedLosses 2023-09-01 2024-08-31 09423979 c:RetainedEarningsAccumulatedLosses 2024-08-31 09423979 c:RetainedEarningsAccumulatedLosses 2023-09-01 09423979 c:AcceleratedTaxDepreciationDeferredTax 2025-08-31 09423979 c:AcceleratedTaxDepreciationDeferredTax 2024-08-31 09423979 d:OrdinaryShareClass1 2024-09-01 2025-08-31 09423979 d:OrdinaryShareClass1 2025-08-31 09423979 d:OrdinaryShareClass1 2024-08-31 09423979 d:FRS102 2024-09-01 2025-08-31 09423979 d:Audited 2024-09-01 2025-08-31 09423979 d:FullAccounts 2024-09-01 2025-08-31 09423979 d:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 09423979 2 2024-09-01 2025-08-31 09423979 f:PoundSterling 2024-09-01 2025-08-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 09423979









CROPTHETICS LIMITED









ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2025

 
CROPTHETICS LIMITED
 
 
COMPANY INFORMATION


Directors
G Singh 
J Walia 




Registered number
09423979



Registered office
Lees Mill Lane
Linthwaite

Huddersfield

West Yorkshire

HD7 5QE




Independent auditors
BKL Audit LLP
Chartered Accountants & Statutory Auditor

London





 
CROPTHETICS LIMITED
 

CONTENTS



Page
Strategic Report
 
 
1 - 3
Directors' Report
 
 
4 - 5
Independent Auditors' Report
 
 
6 - 9
Statement of Income and Retained Earnings
 
 
10
Statement of Financial Position
 
 
11
Notes to the Financial Statements
 
 
12 - 23


 
CROPTHETICS LIMITED
 
 
STRATEGIC REPORT
FOR THE YEAR ENDED 31 AUGUST 2025

Introduction
 
The directors present their strategic report for the period ended 31 August 2025.

Business review
 
Turnover for the 12 month period to 31 August 2025 was £49,299,133, which represents a relative increased in turnover when comparing to the 12 month period to 31 August 2024. This is largely due to external market factors such as recovery by agrochemical market from previous period. There are considerable new registrations along with a new customer base for the new molecules in the market, leading to increased turnover in 2026.

Principal risks and uncertainties
 
The directors have considered the principal risks and uncertainties affecting the company as at 31 August 2025 and up to the date of this report.
The Company's operations expose it to a variety of financial risks that include the effects of changes in credit risk and liquidity risk. The Company has debt finance but does not use derivative financial instruments to manage interest rate and as such, no hedge accounting is applied.
The Company's financial instruments comprise cash and liquid resources, various items such as trade debtors, trade creditors etc, that arise directly from its operations. The main purpose of these financial instruments is to raise finance for the Company's operations. It is, and has been throughout the period under review, the Company's policy that no trading in financial instruments shall be undertaken. The main risks arising from the Company's financial instruments are market risk, credit risk, business and operational risk.

Key performance indicators
 
The Company's key performance indicators during the year were as follows:
Particulars    31.08.2025   31.08.2024 
Turnover          49,299,133         36,532,184 
Gross profit             4,957,305   3,758,514
As a % of sales   10%   10%
Operating results            4,165,124            1,818,946 


Page 1

 
CROPTHETICS LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025

Directors' statement of compliance with duty to promote the success of the Company
 
Section 172 of the Companies Act requires Directors to take into consideration the interests of stakeholders and other matters in their decision making. The Board considers that the decisions they have made during the financial year and the way they have acted have been in the best interests of stakeholders and related parties, having regard for matters set out in s172(1) (a-f) of the Act.
The Board acts in good faith and in a manner that they consider promotes the long-term success of the business for the benefit of its stakeholders. The directors are constantly exploring opportunities to generate additional business. The Company's key stakeholders are its internal staff,financial institutions, clients and suppliers. 
In doing so, the Directors have regard (among other matters) to:
∙The likely consequences of any decision in the long term
∙The interests of the Company’s employees
∙The need to foster business relationships with suppliers, customers, and others
∙The impact of the Company’s operations on the community and the environment
∙The desirability of maintaining a reputation for high standards of business conduct
∙The need to act fairly between members of the Company.

Stakeholder Engagement and Decision-Making

Employees
The Company recognises that its employees are central to its continued success. The Directors aim to maintain a positive and safe working environment, encourage open communication, and support employee development. Regular discussions, feedback mechanisms, and performance reviews ensure that employee interests are considered in key decisions.

Customers
The Company is committed to delivering quality Agrochemical products and services. The Company maintains strong relationships with its customers through consistent product quality, reliability, and responsive service. Customer feedback is actively considered in shaping business strategy and operational improvements.

Suppliers and Partners
The Company values its relationships with suppliers and business partners and seeks to build long-term, mutually beneficial partnerships. The Company ensures fair payment practices and works collaboratively with suppliers to maintain continuity, quality, and cost efficiency across the supply chain.


Community and Environment
As a participant in the agricultural sector, the Company is mindful of its environmental responsibilities. The Directors support sustainable farming and sourcing practices, responsible resource use, and initiatives that minimise environmental impact. The Company also seeks to make a positive contribution to the communities in which it operates.

Business Conduct and Reputation
Maintaining high standards of business conduct is a priority for the Company. The Company operates with integrity, transparency, and accountability in all its dealings. The Directors ensure compliance with all relevant laws and regulations and promote ethical behaviour throughout the organisation.

Shareholders
The Directors are committed to delivering sustainable value for shareholders. Decisions are made with a long-term perspective, balancing risk and return while ensuring the financial stability and growth of the Company. All shareholders are treated fairly and equitably.


 
Page 2

 
CROPTHETICS LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025


Principal Decisions
During the financial year, the Directors made key strategic and operational decisions after considering the factors outlined in Section 172(1). These included:
∙Investment in operational efficiency and infrastructure
∙Strengthening supplier relationships and supply chain reliability
∙Managing costs and maintaining financial resilience
∙Enhancing product quality and customer satisfaction

In each case, the Directors considered the potential impact on all stakeholders and the long-term success of the Company.

The Directors believe that they have acted in a way that promotes the success of the Company while having regard to the interests of its stakeholders and fulfilling their duties under Section 172 of the Companies Act 2006.


This report was approved by the board and signed on its behalf.







J Walia
Director

Date: 11 September 2026

Page 3

 
CROPTHETICS LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 AUGUST 2025

The directors present their report and the financial statements for the year ended 31 August 2025.

Directors' responsibilities statement

The directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:


∙select suitable accounting policies for the Company's financial statements and then apply them consistently;

∙make judgements and accounting estimates that are reasonable and prudent;

∙state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Principal activity

The principal activity of the Company in the year under review was that of trading in and processing of agro chemicals. 

Results and dividends

The profit for the year, after taxation, amounted to £3,122,381 (2024 - £1,373,674).

Dividends of £NIL (2024: £NIL) were declared and paid in the year. 

Directors

The directors who served during the year were:

G Singh 
J Walia 

Future developments

Business prospects are increasing both in terms of geography and product portfolio with an adept team, we are
poised towards growth.

Page 4

 
CROPTHETICS LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025

Greenhouse gas emissions, energy consumption and energy efficiency action

The Company has not disclosed information in respect of greenhouse gas emissions, energy consumption and energy efficiency action as its energy consumption in the United Kingdom for the year is 40,000kWh or lower.

Matters covered in the Strategic Report

The Directors have chosen, in accordance with s414C of the Companies Act, to disclose the information relating to principal risk and uncertainties, review of the business and key performance indicators in the Strategic Report.

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' Report is approved has confirmed that:
 
∙so far as the director is aware, there is no relevant audit information of which the Company's auditors are unaware, and

∙the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Post balance sheet events

There have been no significant events affecting the Company since the year end.

Auditors

Under section 487(2) of the Companies Act 2006, BKL Audit LLP will be deemed to have been reappointed as auditors 28 days after these financial statements were sent to members or 28 days after the latest date prescribed for filing the accounts with the registrar, whichever is earlier.

This report was approved by the board and signed on its behalf.
 







J Walia
Director

Date: 11 September 2026

Page 5

 
CROPTHETICS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF CROPTHETICS LIMITED
 

Opinion


We have audited the financial statements of Cropthetics Limited (the 'Company') for the year ended 31 August 2025, which comprise the Statement of Income and Retained Earnings, the Statement of Financial Position and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


∙give a true and fair view of the state of the Company's affairs as at 31 August 2025 and of its profit for the year then ended;
∙have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
∙have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Page 6

 
CROPTHETICS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF CROPTHETICS LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The directors are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


∙the information given in the Strategic Report and the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
∙the Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Directors' Report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


∙adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
∙the financial statements are not in agreement with the accounting records and returns; or
∙certain disclosures of directors' remuneration specified by law are not made; or
∙we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Directors' Responsibilities Statement set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.


Page 7

 
CROPTHETICS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF CROPTHETICS LIMITED (CONTINUED)


Auditors' responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

∙Enquiring of management and those charged with governance around actual and potential litigation and claims;
∙Enquiring of management and those charged with governance to identify any instances of non-compliance with laws and regulations;
∙Reviewing board meeting minutes for all meetings taking place throughout the year.
∙Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
∙Reviewing the general ledger in detail for all transactions with related parties;
∙Performing walk through testing to ensure systems and controls are operating as recorded where appropriate;
∙Performing audit work over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias.


Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.


As part of an audit in accordance with ISAs (UK), we exercise professional judgement and maintain professional scepticism throughout the audit. We also:


∙Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
∙Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion of the effectiveness of the Company's internal control.
∙Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.
∙Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude
Page 8

 
CROPTHETICS LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF CROPTHETICS LIMITED (CONTINUED)


that a material uncertainty exists, we are required to draw attention in our Auditors' Report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our Auditors' Report. However, future events or conditions may cause the Company to cease to continue as a going concern.
∙Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.


We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.







Nick Bishop FCA (Senior Statutory Auditor)
  
for and on behalf of
BKL Audit LLP
 
Chartered Accountants
Statutory Auditor
  
London

11 September 2026
Page 9

 
CROPTHETICS LIMITED
 
 
STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 31 AUGUST 2025

2025
2024
Note
£
£

  

Turnover
 4 
49,299,133
36,532,184

Cost of sales
  
(44,341,828)
(32,773,670)

Gross profit
  
4,957,305
3,758,514

Administrative expenses
  
(792,181)
(1,939,568)

Operating profit
 5 
4,165,124
1,818,946

Interest receivable and similar income
  
550
1,000

Interest payable and similar expenses
  
(1,885)
(96,272)

Profit before tax
  
4,163,789
1,723,674

Tax on profit
 8 
(1,041,408)
(350,000)

Profit after tax
  
3,122,381
1,373,674

  

  

Retained earnings at the beginning of the year
  
9,439,445
8,065,771

Profit for the year
  
3,122,381
1,373,674

Retained earnings at the end of the year
  
12,561,826
9,439,445


There were no recognised gains and losses for 2025 or 2024 other than those included in the statement of income and retained earnings.

The notes on pages 12 to 23 form part of these financial statements.

Page 10

 
CROPTHETICS LIMITED
REGISTERED NUMBER: 09423979

STATEMENT OF FINANCIAL POSITION
AS AT 31 AUGUST 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 9 
2,193
2,193

  
2,193
2,193

Current assets
  

Stocks
 10 
2,828,806
8,918,165

Debtors
 11 
11,533,846
14,452,033

Cash at bank and in hand
  
5,732,113
2,624,509

  
20,094,765
25,994,707

Creditors: amounts falling due within one year
 12 
(7,534,583)
(16,557,087)

Net current assets
  
 
 
12,560,182
 
 
9,437,620

Total assets less current liabilities
  
12,562,375
9,439,813

Provisions for liabilities
  

Deferred tax
 13 
(548)
(367)

  
 
 
(548)
 
 
(367)

Net assets
  
12,561,827
9,439,446


Capital and reserves
  

Called up share capital 
 14 
1
1

Profit and loss account
 15 
12,561,826
9,439,445

  
12,561,827
9,439,446


The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 






J Walia
Director

Date: 11 September 2026

The notes on pages 12 to 23 form part of these financial statements.

Page 11

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

1.


General information

The principal activity of the company is that of trading in and processing of agro chemicals. 
The Company is a private company limited by shares and registered in England and Wales.
The Registered Office address is Lees Mill Lane, Linthwaite, Huddersfield, West Yorkshire, HD7 5QE.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
∙the requirements of Section 7 Statement of Cash Flows;
∙the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
∙the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
∙the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A;
∙the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of JT Crop Limited as at 31 August 2025 and these financial statements may be obtained from Lees Mill Lane, Linthwaite, Huddersfield, West Yorkshire, HD7 5QE.

 
2.3

Going concern

The financial statements have been prepared on the going concern basis, which assumes that the Company will continue to trade for the foreseeable future, being a period of at least twelve months from the date of approval of these financial statements, and will be able to meet its debts as they fall due.
The directors have a reasonable expectation, based on their assessment of the Company’s financial position and resources that it will continue in operational existence for the foreseeable future, from the date of approval of these financial statements, and will be able to meet its debts as they fall due. The directors therefore continue to adopt the going concern basis of accounting in preparing the annual financial statements.

Page 12

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

2.Accounting policies (continued)

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is Sterling.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.5

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of Agro chemicals and fertilisers

Revenue from the sale of agro chemicals and fertilisers is recognised when all of the following conditions are satisfied:
∙the Company has transferred the significant risks and rewards of ownership to the buyer;
∙the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
∙the amount of revenue can be measured reliably;
∙it is probable that the Company will receive the consideration due under the transaction; and
∙the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.6

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.7

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.8

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 13

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

2.Accounting policies (continued)

 
2.9

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures and fittings
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 14

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

2.Accounting policies (continued)

 
2.11

Stocks

Stocks consist of raw materials and processed agrochemical and fertiliser products and are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a weighted average basis. 

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.12

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.13

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.14

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.
(i) Financial assets
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.
Such assets are subsequently carried at amortised cost using the effective interest method.
At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in the Statement of Income and Retained Earnings.
(ii) Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.
 
Page 15

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

2.Accounting policies (continued)


2.14
Financial instruments (continued)

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.
(iii) Offsetting
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the application of the accounting policies and the reported amounts of assets and liabilities, income and expenses. Actual results may differ from these estimates.
Estimates and underlying assumptions are continually evaluated and are based on historical experience and other factors, including expectations of future events that are reasonable under the circumstances. Revisions to accounting estimates are recognised in the period in which the estimates are revised and in any future periods affected.
There are no key judgements or estimates that impact the figures in these accounts. 

Page 16

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

4.


Turnover

An analysis of turnover by class of business is as follows:


2025
2024
£
£

Sales of processed material
49,299,133
36,532,184


Analysis of turnover by country of destination:

2025
2024
£
£

United Kingdom
10,988,457
8,449,586

Rest of Europe
38,034,322
27,912,632

Rest of the world
276,354
169,966

49,299,133
36,532,184



5.


Operating profit

The operating profit is stated after charging:

2025
2024
£
£

Exchange differences
95,732
504,824

Other operating lease rentals
104,326
146,731


6.


Auditors' remuneration

During the year, the Company obtained the following services from the Company's auditors and their associates:


2025
2024
£
£

Fees payable to the Company's auditors and their associates for the audit of the Company's financial statements
21,400
20,000

The Company has taken advantage of the exemption not to disclose amounts paid for non-audit services as these are disclosed in the consolidated accounts of the parent Company.

Page 17

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

7.


Employees




The average monthly number of employees, including the directors, during the year was as follows:


        2025
        2024
            No.
            No.







Directors
2
2


8.


Taxation


2025
2024
£
£

Corporation tax


Current tax on profits for the year
1,041,227
350,000


Total current tax
1,041,227
350,000

Deferred tax


Origination and reversal of timing differences
181
-

Total deferred tax
181
-


Tax on profit
1,041,408
350,000
Page 18

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
 
8.Taxation (continued)


Factors affecting tax charge for the year

The tax assessed for the year is higher than (2024 - lower than) the standard rate of corporation tax in the UK of 25% (2024 - 25%). The differences are explained below:

2025
2024
£
£


Profit on ordinary activities before tax
4,163,789
1,723,674


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 - 25%)
1,040,947
430,919

Effects of:


Expenses not deductible for tax purposes
461
778

Non-taxable income
-
(10,531)

Other differences leading to an increase (decrease) in the tax charge
-
13,710

Group relief
-
(84,876)

Total tax charge for the year
1,041,408
350,000


Factors that may affect future tax charges

There were no factors that may affect future tax charges.

Page 19

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

9.


Tangible fixed assets





Fixtures and fittings

£



Cost 


At 1 September 2024
4,100



At 31 August 2025

4,100



Depreciation


At 1 September 2024
1,907



At 31 August 2025

1,907



Net book value



At 31 August 2025
2,193



At 31 August 2024
2,193


10.


Stocks

2025
2024
£
£

Finished goods and goods for resale
2,828,806
8,918,165

2,828,806
8,918,165



11.


Debtors

2025
2024
£
£



Trade debtors
2,157,832
13,919,671

Amounts owed by group undertakings
6,320,470
-

Other debtors
3,055,544
532,362

11,533,846
14,452,033


Amounts owed by group undertakings are unsecured, interest free and repayable on demand. 

Page 20

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

12.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
681,459
8,509,972

Amounts owed to group undertakings
4,315,245
3,080,053

Corporation tax
630,478
927,849

Other taxation and social security
33,020
131,919

Other creditors
808,937
2,175,924

Accruals and deferred income
1,065,444
1,731,370

7,534,583
16,557,087


Amounts owed to group undertakings are unsecured, interest free and repayable on demand. 


13.


Deferred taxation




2025


£






At beginning of year
(367)


Charged to profit or loss
(181)



At end of year
(548)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Accelerated capital allowances
(548)
(367)

(548)
(367)


14.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



1 (2024 - 1) Ordinary share of £1.00
1
1


Page 21

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

15.


Reserves

Profit and loss account

The profit and loss account represents total undistributed profits less losses and dividends declared.


16.


Contingent liabilities

HSBC Bank has a fixed and floating charge over all present and future assets of the company to cover loans, overdrafts and an invoice facility provided to its group companies.
An unlimited Multilateral Guarantee is given by the Company, JT Crop Limited, JT Grosvenor Limited, JT Agro Limited and Widecover Holdings Limited.


17.


Transactions with directors

The company advanced a loan of £11,550 to a director. The loan is unsecured, carries interest at 5% per annum and is repayable on demand.
At the balance sheet date, the balance outstanding was £11,550 (2024: £11,000).
Interest charged on the loan during the current year amounted to £550 (2024: £1,000).


18.


Related party transactions

The Company has taken advantage of the exemption conferred by FRS 102 section 33.1A from the requirement to disclose transactions with other wholly owned group undertakings.

2025
2024
£
£

Sales
87,619
408,909
Purchases
6,581,287
9,480,506
Amount due from related party
5,661,727
569,865
Amount due to related party
2,722,970
5,926,726

The above companies are related by virtue of common control.


19.


Post balance sheet events

There have been no significant events affecting the Company since the year end.

Page 22

 
CROPTHETICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

20.


Controlling party

The Company's immediate parent company is JT Agro Limited, a company incorporated in England & Wales.
The ultimate controlling party is JT Crop Limited, a company incorporated in England & Wales.
The Registered Office and principal place of business of JT Crop Limited is Lees Mill Lane, Linthwaite, Huddersfield, West Yorkshire, HD7 5QE.

 
Page 23